Approximately 400 million people are chronic HBV surface antigen carriers.There is a pressing need to improve therapeutic options for chronic hepatitis B.Pegylated interferon alpha (Peg-IFN-α) achieve
Background: Macrophages, the nucleating cells and predominant constituent members of tuberculous granuloma, play key roles in the formation and development of tuberculous granuloma.
Background: More than 60% of patients infected with hepatitis B virus (HBV) regarded as NR have a diminished HBV virologic response to standard interferon (IFN)-based therapies.
Introduction: Currently Tuberculosis (TB) is still a serious public health challenge that contributes significantly to illness and death around the world.